Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Neoplasms 1

Interventions

pembrolizumab 2 Paclitaxel 2 Carboplatin 2 ulixertinib 1 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 trametinib 1 sapanisertib 1 relatlimab 1 pertuzumab 1 palbociclib 1 osimertinib 1 omipalisib 1 larotrectinib 1 ipatasertib 1 erdafitinib 1 defactinib 1 dabrafenib 1 copanlisib 1 capivasertib 1 binimetinib 1 adavosertib 1 X-Rays 1 Vaginal Smears 1 Trastuzumab 1 Sutures 1 Sunitinib 1 Specimen Handling 1 Radionuclide Imaging 1 Papanicolaou Test 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Neoplasms × 16-fluoroestradiol × 30 days × Clear all

NCT05916196 2026-06-05

[18F]FES PET/.CT in Uterine Cancer

Abramson Cancer Center at Penn Medicine

Phase 2 Recruiting

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡